The University of Wisconsin, Department of Biomedical Engineering, 1550 Engineering Drive, Madison, WI 53705, USA.
Acta Biomater. 2011 Mar;7(3):975-85. doi: 10.1016/j.actbio.2010.10.026. Epub 2010 Oct 26.
Dynamic hydrogels have emerged as an important class of biomaterials for temporal control over growth factor delivery. In this study we formed dynamic hydrogel microspheres from protein-polymer conjugates using an aqueous two-phase suspension polymerization process. This polymerization process enabled rapid microsphere formation without the use of an organic phase, surfactants, mechanical strain or toxic radical initiators. The microspheres' size distribution was modulated by varying the protein-polymer conformation in the pre-polymer solution. Notably, the protein's ligand-induced, nanometer-scale conformational change translated to maximum hydrogel volume changes of 76±10%. The magnitude of the microspheres' volume change was tuned by varying the crosslinking time and ligand identity. After characterizing the microspheres' dynamic properties, we encapsulated two important therapeutic proteins, vascular endothelial growth factor (VEGF) and bone morphogenetic protein-2 (BMP-2), in the hydrogel microspheres and characterized how the microspheres' dynamic properties controlled their release. Significantly, the aqueous two-phase suspension polymerization process enabled high encapsulation efficiencies (65.8±4.8% and 79.5±3.0% for VEGF and BMP-2, respectively). Also, the microspheres' ligand-induced volume change triggered VEGF and BMP-2 release at specific, predetermined times. There are hundreds of proteins that undergo well-characterized conformational changes that could be processed into hydrogel microspheres via aqueous two-phase suspension polymerizations. Therefore, this approach could be used to form dynamic, growth-factor-releasing hydrogel microspheres that respond to a broad range of specific biochemical ligands.
动态水凝胶作为一种重要的生物材料类别,已被用于实现对生长因子释放的时间控制。在本研究中,我们使用水相两亲悬浮聚合工艺,从蛋白-聚合物偶联物中形成动态水凝胶微球。该聚合工艺能够在不使用有机溶剂、表面活性剂、机械应变或有毒自由基引发剂的情况下,快速形成微球。通过改变预聚物溶液中蛋白-聚合物的构象,调节了微球的粒径分布。值得注意的是,蛋白配体诱导的纳米级构象变化转化为水凝胶体积的最大变化 76±10%。通过改变交联时间和配体的种类,可调节微球体积变化的幅度。在对微球的动态特性进行表征后,我们将两种重要的治疗性蛋白(血管内皮生长因子(VEGF)和骨形态发生蛋白-2(BMP-2))包封在水凝胶微球中,并研究了微球的动态特性如何控制其释放。重要的是,水相两亲悬浮聚合工艺能够实现高包封效率(VEGF 和 BMP-2 的包封效率分别为 65.8±4.8%和 79.5±3.0%)。此外,微球的配体诱导体积变化触发了 VEGF 和 BMP-2 的特定预定时间释放。有数百种蛋白经历了特征明确的构象变化,可以通过水相两亲悬浮聚合工艺转化为水凝胶微球。因此,这种方法可用于形成对广泛的特定生化配体产生响应的动态、生长因子释放的水凝胶微球。